Target intelligence / Profile preview

C-C motif chemokine ligand 4-like 2 (CCL4L2)

Target
CCL4L2
Molecular classification
Chemokine, Cytokine, CC chemokine family, Immune signaling molecule
01

Overview

C-C motif chemokine ligand 4-like 2 (CCL4L2) is a member of the CC chemokine cytokine family, acting as a non-allelic copy of CCL4 with only a single amino acid difference[2]. CCL4L2 is involved in immune regulation and inflammation, primarily by encoding a chemotactic signaling protein that recruits and activates immune cells such as pro-inflammatory (M1) macrophages at sites of injury or disease[2]. Its expression is increased in inflammatory states and contributes to chronic inflammation and tissue damage, notably in tendinopathy and autoimmune diseases. CCL4L2 impacts cell signaling that inhibits tendon stromal progenitor cell (TSPC) differentiation, promotes macrophage-driven inflammation, and disrupts tissue repair processes. It is considered a potential therapeutic target for inflammatory disease modulation and a candidate biomarker in conditions such as tendinopathy and other chronic inflammatory diseases[2].

Other names
C-C motif chemokine 4-likeCCL4L1CCL4LLAG1SCYA4L1SCYA4L2LAG-1MIP-1-betaLymphocyte activation gene 1 proteinMacrophage inflammatory protein 1-betaMonocyte adherence-induced protein 5-alphaSmall-inducible cytokine A4-likeAT744.2SCYQ4L2
02

Mechanism of action

null

03

Biological functions

Immune responseInflammatory responseChemotaxis (attracts immune cells such as macrophages)Regulation of macrophage polarization (specifically M1 pro-inflammatory macrophages)
04

Disease associations

InflammationChronic inflammatory diseases (e.g., bronchial asthma, chronic arthritis, sarcoidosis)Viral myocarditisTendinopathy progression (implicated in tendon injury and repair dysfunction)
05

Safety considerations

Modulating CCL4L2 may alter systemic immune responses, increasing risk for impaired healing or excessive inflammation[2].Targeting chemokine pathways may risk unintended immunosuppression or autoimmune effects.
06

Biomarkers

Potential biomarker in tendinopathyMarker of M1 macrophage enrichment in inflamed tissues

Beyond the preview

Go deeper on C-C motif chemokine ligand 4-like 2 (CCL4L2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on C-C motif chemokine ligand 4-like 2 (CCL4L2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call